Media September 22, 2025: Interview of Eric Soyer, CFO at MaaT Pharma – Boursier.com (French Only) MaaT PharmaSeptember 23, 2025
Media August 7, 2025: French Tech : Maat Pharma traite les complications de greffe de moelle osseuse – BFM Business (French Only) MaaT PharmaAugust 8, 2025
Media July 21, 2025: World’s First Hemato-Oncology Microbiota Therapeutic Among Latest New EU Filings – Citeline MaaT PharmaJuly 22, 2025
Media June 25, 2025: Just the Two of Us: Creating Microbiomes to Fight Cancer, ALS, and More – Inside Precision Medicine MaaT PharmaJune 27, 2025
Media June 6, 2025: Eric Soyer, directeur financier Maat Pharma : “demande d’autorisation de mise sur le marché” – Lyon Décideurs (French Only) MaaT PharmaJune 12, 2025
Media June 6, 2025: Biothérapie : le lyonnais MaaT Pharma franchit un cap avec son traitement à base de microbiote – La Tribune (French Only) MaaT PharmaJune 12, 2025
Media May 15, 2025: MaaT Pharma : Présentation investisseurs, Stratégie et Perspectives 2025 – La Bourse et La Vie (French Only) MaaT PharmaMay 15, 2025
Media May 13, 2025: Microbiome-Targeting Therapy MaaT033 Continues to Show Promise in Final Phase 1 Readout – Neurology Live MaaT PharmaMay 13, 2025
Media May 12, 2025: 3 Questions à MaaT Pharma – Direct Dirigeants (subtitled in English) MaaT PharmaMay 12, 2025
Media April 29, 2025: AACR 2025: MaaT Pharma, the gut microbiome, and immuno-oncology – Pharmaphorum MaaT PharmaApril 29, 2025
